Randomized comparison of 2 protocols to prevent acquisition of methicillin-resistant Staphylococcus aureus: Results of a 2-Center study involving 500 patients

Infection Control and Hospital Epidemiology

Volumn 32, Issue 11, 2011, Pages 1064-1072

  Camus, Christophe ^a,b   Bellissant, Eric ^a,b   Legras, Annick ^c   Renault, Alain ^a,b   Gacouin, Arnaud ^a   Lavoué, Sylvain ^a   Branger, Bernard ^a   Donnio, Pierre Yves ^a   le Corre, Pascal ^a   Le Tulzo, Yves ^a   Perrotin, Dominique ^c   Thomas, Rémi ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; HYGIENE; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; CROSS INFECTION; FEMALE; FRANCE; GUIDELINE ADHERENCE; HOSPITALS, TEACHING; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MUPIROCIN; NOSE; PATIENT ISOLATION; STAPHYLOCOCCAL INFECTIONS;

EID: 80054854582     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/662180     Document Type: Article

References (38)

1. Legras A, Malvy D, Quinioux AI, et al. Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Med 1998;24:1040-1046.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995;274:639-644.
3. Garner JS; The Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53-80.
4. Fridkin S, Gaynes R. Antimicrobial resistance in intensive care units. Clin Chest Med 1999;20:303-316.
5. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:481-498.
6. McDougal LK, Steward CD, Killgore GE, Chaitram JM, Mc-Allister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41:5113-5120.
7. Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/ mdroGuideline2006.pdf.
8. Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409-418.
9. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-2963.
10. Camus C, Bellissant E, Sebille V, et al. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med 2005;33:307-314.
11. Centers for Disease Control and Prevention. Guideline for isolation precautions in hospitals. Am J Infect Control 1996;24: 24-52.
12. Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Members of the SFM Antibiogram Committee. Int J Antimicrob Agents. 2003;21:364-391.
13. Gould IM. The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2005;61:277-282.
14. Boyce JM, Havill NL, Kohan C, Dumigan DG, Ligi CE. Do infection control measures work for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2004;25:395-401.
15. Gould IM, MacKenzie FM, MacLennan G, Pacitti D, Watson EJ, Noble DW. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 2007;29:536-543.
16. Pan A, Carnevale G, Catenazzi P, et al. Trends in methicillinresistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA. Infect Control Hosp Epidemiol 2005;26:127-133.
17. Raineri E, Crema L, De Silvestri A, et al. Methicillin-resistant Staphylococcus aureus control in an intensive care unit: a 10 year analysis. J Hosp Infect 2007;67:308-315.
18. Lucet JC, Paoletti X, Lolom I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051-1057.
19. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971-978.
20. Torgerson DJ. Contamination in trials: is cluster randomisation point the answer? BMJ 2001;322:355-357.
21. Slymen DJ, Hovell MF. Cluster versus individual randomization in adolescent tobacco and alcohol studies: illustrations for design decisions. Int J Epidemiol 1997;26:765-771.
22. Johnson PD, Martin R, Burrell LJ, et al. Efficacy of an alcohol/ chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005;183:509-514.
23. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene (published correction appears in Lancet 2000;356:2196). Lancet 2000;356:1307-1312.
24. Grayson ML, Jarvie LJ, Martin R, et al. Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culturechange program and subsequent successful statewide roll-out. Med J Aust 2008;188:633-640.
25. Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130: 126-130.
26. Ridenour GA, Wong ES, Call MA, Climo MW. Duration of colonization with methicillin-resistant Staphylococcus aureus among patients in the intensive care unit: implications for intervention. Infect Control Hosp Epidemiol 2006;27:271-278.
27. Lucet JC, Grenet K, Armand-Lefevre L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005;26: 121-126.
28. Cooper BS, Stone SP, Kibbler CC, et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. BMJ 2004; 329(7465):533-538.
29. Troché G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 2005;26:161-165.
30. Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149-1157.
31. Edmond MB, Ober JF, Bearman G. Active surveillance cultures are not required to control MRSA infections in the critical care setting. Am J Infect Control 2008;36:461-463.
32. Jernigan JA, Titus MG, Gröschel DH, Getchell-White S, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
33. Mangini E, Segal-Maurer S, Burns J, et al. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol 2007;28:1261-1266.
34. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.
35. Harbarth S, Liassine N, Dharan S, Herrault P, Auckenthaler R, Pittet D. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000;31:1380-1385.
36. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillinresistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37: 1858-1865.
37. Wendt C, Schinke S, Württemberger M, Oberdorfer K, Bock-Hensley O, von Baum H. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, doubleblind clinical trial. Infect Control Hosp Epidemiol 2007;28: 1036-1043.
38. Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:1155-1161.